#METABOLOMICS WORKBENCH fabio_moraes_20241128_110632 DATATRACK_ID:5411 STUDY_ID:ST003602 ANALYSIS_ID:AN005918 PROJECT_ID:PR002230 VERSION 1 CREATED_ON December 5, 2024, 10:20 am #PROJECT PR:PROJECT_TITLE Metabolic effects of cellular necrosis caused by exfoliative toxin C (ExhC) from PR:PROJECT_TITLE Mammaliccocus sciuri PR:PROJECT_TYPE Untargetd NMR-based metabolomics PR:PROJECT_SUMMARY Exfoliative toxins (ETs) are glutamyl endopeptidases (GEPs) of the PR:PROJECT_SUMMARY chymotrypsin-like serine protease family (CLSPs) that play crucial roles in PR:PROJECT_SUMMARY diverse skin diseases. Specifically, exfoliative toxin C (ExhC), expressed by PR:PROJECT_SUMMARY Mammaliicoccus sciuri, is an atypical CLSP and is been classified as a PR:PROJECT_SUMMARY moonlighting protein due to its ability to induce necrosis in specific cell PR:PROJECT_SUMMARY lines, inhibits the phagocytic activity of macrophages, and causes skin PR:PROJECT_SUMMARY exfoliation in pigs and mice. The latter function is due to the high specificity PR:PROJECT_SUMMARY of ExhC for porcine and murine desmoglein-1, a cadherin that contributes to PR:PROJECT_SUMMARY cell-cell adhesion within the epidermis. While the amino acid residues PR:PROJECT_SUMMARY responsible for ExhC-induced necrosis have been identified, the specific PR:PROJECT_SUMMARY cellular metabolic pathways it affects to induce cell death remain unclear. PR:PROJECT_SUMMARY Herein, we employed Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) PR:PROJECT_SUMMARY to explore the metabolic pathways affected by the necrotic activity of ExhC in PR:PROJECT_SUMMARY the BHK-21 cell line. The metabolic profile of cells exposed to sub-toxic doses PR:PROJECT_SUMMARY of ExhC revealed significant alterations in oxidative stress protection, energy PR:PROJECT_SUMMARY production, and gene expression pathways. The data demonstrate the potential PR:PROJECT_SUMMARY mechanisms of action of ExhC and highlight that this toxin causes cellular PR:PROJECT_SUMMARY damage, even at low concentrations. PR:INSTITUTE São Paulo State University - UNESP PR:DEPARTMENT Physics Department (Rio Preto) PR:LABORATORY NMR Laboratory PR:LAST_NAME de Moraes PR:FIRST_NAME Fábio PR:ADDRESS Cristóvão Colombo Street, 2265 PR:EMAIL fabio.moraes@unesp.br PR:PHONE 1732212454 PR:FUNDING_SOURCE Fapesp and CNPq PR:PROJECT_COMMENTS FAPESP, #2020/08615-8 and CNPq, #309940/2019-2 PR:PUBLICATIONS to be submitted PR:CONTRIBUTORS Carolina Gismene, Fábio Rogério de Moraes, Anelize Bauermeister, Thyerre PR:CONTRIBUTORS Santana Da Costa, Marília Freitas Calmon, Paula Rahal, Rejane Maira Góes, Luiz PR:CONTRIBUTORS Alberto Beraldo de Moraes, Ljubica Tasic, Raghuvir Krishnaswamy Arni #STUDY ST:STUDY_TITLE Metabolic effects of cellular necrosis caused by exfoliative toxin C (ExhC) from ST:STUDY_TITLE Mammaliccocus sciuri ST:STUDY_SUMMARY Exfoliative toxins (ETs) are glutamyl endopeptidases (GEPs) of the ST:STUDY_SUMMARY chymotrypsin-like serine protease family (CLSPs) that play crucial roles in ST:STUDY_SUMMARY diverse skin diseases. Specifically, exfoliative toxin C (ExhC), expressed by ST:STUDY_SUMMARY Mammaliicoccus sciuri, is an atypical CLSP and is been classified as a ST:STUDY_SUMMARY moonlighting protein due to its ability to induce necrosis in specific cell ST:STUDY_SUMMARY lines, inhibits the phagocytic activity of macrophages, and causes skin ST:STUDY_SUMMARY exfoliation in pigs and mice. The latter function is due to the high specificity ST:STUDY_SUMMARY of ExhC for porcine and murine desmoglein-1, a cadherin that contributes to ST:STUDY_SUMMARY cell-cell adhesion within the epidermis. While the amino acid residues ST:STUDY_SUMMARY responsible for ExhC-induced necrosis have been identified, the specific ST:STUDY_SUMMARY cellular metabolic pathways it affects to induce cell death remain unclear. ST:STUDY_SUMMARY Herein, we employed Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) ST:STUDY_SUMMARY to explore the metabolic pathways affected by the necrotic activity of ExhC in ST:STUDY_SUMMARY the BHK-21 cell line. The metabolic profile of cells exposed to sub-toxic doses ST:STUDY_SUMMARY of ExhC revealed significant alterations in oxidative stress protection, energy ST:STUDY_SUMMARY production, and gene expression pathways. The data demonstrate the potential ST:STUDY_SUMMARY mechanisms of action of ExhC and highlight that this toxin causes cellular ST:STUDY_SUMMARY damage, even at low concentrations. ST:INSTITUTE São Paulo State University - UNESP ST:DEPARTMENT Physics Department (Rio Preto) ST:LABORATORY NMR Laboratory ST:LAST_NAME de Moraes ST:FIRST_NAME Fábio ST:ADDRESS Cristóvão Colombo Street, 2265 ST:EMAIL fabio.moraes@unesp.br ST:PHONE 1732212454 ST:NUM_GROUPS 2 ST:TOTAL_SUBJECTS 16 #SUBJECT SU:SUBJECT_TYPE Cultured cells SU:SUBJECT_SPECIES Mesocricetus Auratus #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS - C1 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C1 SUBJECT_SAMPLE_FACTORS - C2 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C2 SUBJECT_SAMPLE_FACTORS - C3 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C3 SUBJECT_SAMPLE_FACTORS - C4 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C4 SUBJECT_SAMPLE_FACTORS - C5 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C5 SUBJECT_SAMPLE_FACTORS - C6 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C6 SUBJECT_SAMPLE_FACTORS - C7 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C7 SUBJECT_SAMPLE_FACTORS - C8 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C8 SUBJECT_SAMPLE_FACTORS - C9 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C9 SUBJECT_SAMPLE_FACTORS - C10 Sample source:BHK-21 | Treatment:Control RAW_FILE_NAME(Raw file name)=Files under the folder C10 SUBJECT_SAMPLE_FACTORS - T1 Sample source:BHK-21 | Treatment:Treatment with Toxin RAW_FILE_NAME(Raw file name)=Files under the folder T1 SUBJECT_SAMPLE_FACTORS - T2 Sample source:BHK-21 | Treatment:Treatment with Toxin RAW_FILE_NAME(Raw file name)=Files under the folder T2 SUBJECT_SAMPLE_FACTORS - T3 Sample source:BHK-21 | Treatment:Treatment with Toxin RAW_FILE_NAME(Raw file name)=Files under the folder T3 SUBJECT_SAMPLE_FACTORS - T4 Sample source:BHK-21 | Treatment:Treatment with Toxin RAW_FILE_NAME(Raw file name)=Files under the folder T4 SUBJECT_SAMPLE_FACTORS - T5 Sample source:BHK-21 | Treatment:Treatment with Toxin RAW_FILE_NAME(Raw file name)=Files under the folder T5 #COLLECTION CO:COLLECTION_SUMMARY Around 1.2 x 107 BHK-21 cells were seeded in 60 mm plates for 24 h and, then, CO:COLLECTION_SUMMARY treated with 7.5 µmol.L-1 of ExhC for 48 h. After treatment, the cells were CO:COLLECTION_SUMMARY detached with 0.25% trypsin-EDTA (0.25%) (Gibco - Thermo Fisher Scientific, CO:COLLECTION_SUMMARY Waltham, MA, USA), followed by two washes with PBS 1x, and the addition of 2 mL CO:COLLECTION_SUMMARY of 80% methanol (Sigma-Aldrich). The cell solution was vortexed for one minute CO:COLLECTION_SUMMARY followed by centrifugation at 4000 rpm for 20 min at 4 °C. The aqueous extract CO:COLLECTION_SUMMARY obtained was lyophilized in a vacuum centrifuge (Concentrator 5301, Eppendorf, CO:COLLECTION_SUMMARY Hamburg, Germany) and stored in the freezer at -80 °C. The extraction of CO:COLLECTION_SUMMARY intracellular metabolites was also performed with 1.2 x 107 of BHK-21 cells CO:COLLECTION_SUMMARY after 48 h of growth in DMEM medium, representing the control experiment. CO:COLLECTION_SUMMARY Overall, five samples of intracellular metabolites were obtained in the presence CO:COLLECTION_SUMMARY of ExhC (i) and ten samples of intracellular metabolites were obtained in the CO:COLLECTION_SUMMARY absence of ExhC (ii). The intracellular samples were diluted in 700 µL of CO:COLLECTION_SUMMARY deuterium oxide with 3-(trimethylsilyl)propionic-2,2,3,3-d₄ acid sodium salt - CO:COLLECTION_SUMMARY TSP (D2O 99.9%, Sigma Aldrich) and transferred to 5 mm tubes for data CO:COLLECTION_SUMMARY acquisition by Nuclear Magnetic Resonance (NMR). CO:COLLECTION_PROTOCOL_FILENAME ExhC_protocol.pdf CO:SAMPLE_TYPE Kidney #TREATMENT TR:TREATMENT_SUMMARY Around 1.2 x 107 BHK-21 cells were seeded in 60 mm plates for 24 h and, then, TR:TREATMENT_SUMMARY treated with 7.5 µmol.L-1 of ExhC for 48 h. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY After treatment, the cells were detached with 0.25% trypsin-EDTA (0.25%) (Gibco SP:SAMPLEPREP_SUMMARY - Thermo Fisher Scientific, Waltham, MA, USA), followed by two washes with PBS SP:SAMPLEPREP_SUMMARY 1x, and the addition of 2 mL of 80% methanol (Sigma-Aldrich). The cell solution SP:SAMPLEPREP_SUMMARY was vortexed for one minute followed by centrifugation at 4000 rpm for 20 min at SP:SAMPLEPREP_SUMMARY 4 °C. The aqueous extract obtained was lyophilized in a vacuum centrifuge SP:SAMPLEPREP_SUMMARY (Concentrator 5301, Eppendorf, Hamburg, Germany) and stored in the freezer at SP:SAMPLEPREP_SUMMARY -80 °C. The extraction of intracellular metabolites was also performed with 1.2 SP:SAMPLEPREP_SUMMARY x 107 of BHK-21 cells after 48 h of growth in DMEM medium, representing the SP:SAMPLEPREP_SUMMARY control experiment. Overall, five samples of intracellular metabolites were SP:SAMPLEPREP_SUMMARY obtained in the presence of ExhC (i) and ten samples of intracellular SP:SAMPLEPREP_SUMMARY metabolites were obtained in the absence of ExhC (ii). The intracellular samples SP:SAMPLEPREP_SUMMARY were diluted in 700 µL of deuterium oxide with SP:SAMPLEPREP_SUMMARY 3-(trimethylsilyl)propionic-2,2,3,3-d₄ acid sodium salt - TSP (D2O 99.9%, SP:SAMPLEPREP_SUMMARY Sigma Aldrich) and transferred to 5 mm tubes for data acquisition by Nuclear SP:SAMPLEPREP_SUMMARY Magnetic Resonance (NMR). #ANALYSIS AN:SOFTWARE_VERSION TopSpin 4.4.0 #NMR NM:INSTRUMENT_NAME Bruker NM:INSTRUMENT_TYPE FT-NMR NM:NMR_EXPERIMENT_TYPE 1D-1H NM:SPECTROMETER_FREQUENCY 600 MHz NM:NMR_PROBE triple resonance broadband inverse probe (PH TBI 600S3) NM:NMR_SOLVENT 90% H2O + 10% D2O NM:NMR_TUBE_SIZE 5mm NM:PULSE_SEQUENCE 1D Carr-Purcell-Meiboom-Gill NM:WATER_SUPPRESSION pre saturation NM:PULSE_WIDTH 9.2 us NM:POWER_LEVEL 17.378 W NM:RECEIVER_GAIN 203 NM:OFFSET_FREQUENCY 0.5 NM:PRESATURATION_POWER_LEVEL -42.30 dBW NM:CHEMICAL_SHIFT_REF_CPD TSP NM:TEMPERATURE 25 NM:NUMBER_OF_SCANS 128 NM:ACQUISITION_TIME 3.89 NM:RELAXATION_DELAY 4s NM:SPECTRAL_WIDTH 14 ppm #NMR_METABOLITE_DATA NMR_METABOLITE_DATA:UNITS TSP_normalized NMR_METABOLITE_DATA_START Samples C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 T1 T2 T3 T4 T5 Factors Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Control Sample source:BHK-21 | Treatment:Treatment with Toxin Sample source:BHK-21 | Treatment:Treatment with Toxin Sample source:BHK-21 | Treatment:Treatment with Toxin Sample source:BHK-21 | Treatment:Treatment with Toxin Sample source:BHK-21 | Treatment:Treatment with Toxin AMP 0.0017 0.0018 0.0016 0.0017 0.0017 0.0016 0.0016 0.0016 0.0015 0.0016 0.0011 0.001 0.0009 0.0008 0.0008 IMP 0.0016 0.0016 0.0017 0.0015 0.0015 0.0014 0.0018 0.0017 0.0015 0.0015 0.0032 0.0033 0.0037 0.0023 0.0022 Formate 0.0373 0.0378 0.038 0.0369 0.0362 0.0362 0.036 0.0358 0.0356 0.0357 0.0029 0.0014 0.002 0.0014 0.0005 NADP+ 0.0003 0.0004 0.0004 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0003 0.0006 0.0009 0.0008 0.0009 0.0004 NAD+ 0.0013 0.0013 0.0013 0.0012 0.0012 0.0012 0.0012 0.0012 0.0012 0.0012 0.0013 0.0013 0.0015 0.0014 0.001 ATP 0.0012 0.0011 0.0012 0.0012 0.0011 0.0011 0.0012 0.0011 0.0012 0.0011 0.0009 0.0007 0.0007 0.0007 0.0006 GTP 0.0001 0.0002 0.0002 0.0001 0.0001 0.0002 0.0001 0.0001 0.0001 0.0001 0.0007 0.0007 0.0007 0.0007 0.0003 UMP 0.0014 0.0015 0.0016 0.0015 0.0015 0.0014 0.0015 0.0015 0.0014 0.0017 0.0016 0.0008 0.0009 0.0008 0.0005 UDP_variants 0.0075 0.0078 0.008 0.0077 0.0076 0.0078 0.0075 0.0076 0.0075 0.0076 0.004 0.0049 0.0071 0.0056 0.0039 Tau-Methylhistidine 0 0.0001 0.0001 0.0001 0.0001 0.0001 0 0.0001 0 0 0.001 0.0007 0.0013 0.0007 0.0009 Tryptophan 0.0011 0.0013 0.0012 0.0011 0.0012 0.001 0.0012 0.0011 0.0011 0.0012 0.0008 0.0007 0.0009 0.0007 0.0007 Phenylalanine 0.0092 0.0096 0.0101 0.0096 0.0094 0.0094 0.0093 0.0095 0.0096 0.0091 0.0071 0.0052 0.0076 0.0059 0.0061 Tyrosine 0.0126 0.0127 0.0133 0.0128 0.0122 0.0123 0.0123 0.0123 0.0123 0.0124 0.0086 0.0067 0.0091 0.0072 0.0081 Fumarate 0.0001 0.0001 0.0002 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0002 0.0001 0.0002 0.0002 0.0001 Glucose-Galactose 0.0006 0.0015 0.0023 0.0009 0.0002 0.0002 0.0003 0.0003 0.0003 0.0002 0.004 0.002 0.0015 0.0005 0.0005 Proline 0.004 0.0043 0.0047 0.0039 0.0036 0.0037 0.0037 0.0038 0.0037 0.0036 0.003 0.0024 0.0032 0.0028 0.0023 Lactate 0.0059 0.0062 0.0063 0.0059 0.0056 0.0056 0.0055 0.0056 0.0055 0.0055 0.006 0.0042 0.005 0.0031 0.004 Creatine 0.0486 0.0491 0.0494 0.0486 0.0484 0.0485 0.0483 0.0484 0.0482 0.0484 0.0537 0.042 0.0549 0.0608 0.0444 Methylamine 0.0022 0.0026 0.0024 0.0024 0.0023 0.0023 0.0023 0.0023 0.0023 0.0022 0.0018 0.0014 0.0017 0.0017 0.0013 Beta-Alanine 0.0187 0.0194 0.0197 0.0192 0.0188 0.0192 0.0194 0.0193 0.0197 0.0197 0.0189 0.0156 0.0182 0.0197 0.0133 Succinate 0.0048 0.0048 0.0049 0.0048 0.0046 0.0047 0.0046 0.0047 0.0047 0.0046 0.0065 0.0032 0.0029 0.0032 0.0033 Acetate 0.0691 0.0697 0.0701 0.0691 0.0685 0.0689 0.0687 0.0689 0.0687 0.0691 0.0282 0.011 0.0205 0.0103 0.0038 Butyrate 0.0021 0.0024 0.0024 0.0023 0.0023 0.0022 0.0021 0.0022 0.0023 0.0022 0.002 0.0019 0.0021 0.0021 0.002 Alanine 0.0486 0.0499 0.0503 0.0484 0.0475 0.0478 0.0476 0.0475 0.0475 0.0477 0.0524 0.031 0.0408 0.0321 0.0371 Valine 0.0286 0.0293 0.03 0.0288 0.0281 0.0281 0.0283 0.0284 0.0282 0.0282 0.0214 0.0158 0.0218 0.0171 0.016 Isoleucine 0.0242 0.0248 0.0255 0.0244 0.0237 0.024 0.0239 0.024 0.0239 0.0242 0.0181 0.0138 0.0194 0.0148 0.0151 Leucine 0.025 0.0244 0.0253 0.0249 0.0252 0.0248 0.0252 0.0253 0.0247 0.0247 0.0184 0.0144 0.02 0.0149 0.0158 Valerate 0.0022 0.0023 0.0023 0.0022 0.0022 0.0023 0.0023 0.0023 0.0022 0.0021 0.0021 0.0024 0.0026 0.0028 0.0025 NMR_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name AMP IMP Formate NADP+ NAD+ ATP GTP UMP UDP_variants Tau-Methylhistidine Tryptophan Phenylalanine Tyrosine Fumarate Glucose-Galactose Proline Lactate Creatine Methylamine Beta-Alanine Succinate Acetate Butyrate Alanine Valine Isoleucine Leucine Valerate METABOLITES_END #END